DNAJC19

DNAJC19 (Tim14/Pam18) is an inner mitochondrial membrane J-protein that functions as the essential J-domain cochaperone of the TIM23 presequence translocase-associated import motor, stimulating the ATPase activity of mtHsp70 to drive ATP-dependent translocation of precursor proteins into the matrix (PMID:14517234). Its activity is governed by an obligate heterodimer with the J-like protein Tim16/Pam16: structural and biochemical work shows the two share nearly identical folds but distinct surfaces, with Tim16 tightly regulating DNAJC19's cochaperone output, and disruption of the complex being lethal (PMID:15218029, PMID:16977310). Heterodimer formation also stabilizes both subunits and tethers DNAJC19 to the translocon, where Tim16 makes the major contacts via its N-terminal hydrophobic segment and the matrix face of the channel while the DNAJC19 IMS domain engages Tim17, so that loss of heterodimer integrity strips DNAJC19 from the translocon and impairs matrix import (PMID:18003975, PMID:17452317, PMID:17242434). Beyond import, DNAJC19 has a second function: it associates with prohibitin (PHB) membrane domains in the inner membrane to organize tafazzin-mediated cardiolipin remodeling, and its loss produces defective cristae morphogenesis and accumulation of cardiolipin species with altered acyl chains (PMID:24856930). Truncation removing the DnaJ interaction domain causes mitochondrial fragmentation, abnormal cristae, altered substrate utilization, elevated ROS and dysregulated Ca2+ handling in cardiomyocytes (PMID:38142971). A splice-site mutation in DNAJC19 causes dilated cardiomyopathy with ataxia (DCMA) syndrome (PMID:16055927).

1. 2003 High

   Established that the yeast ortholog Tim14 is an essential matrix-facing J-protein of the TIM23 import motor that drives mtHsp70-powered protein import, defining the core molecular activity of this protein family.

   Evidence Genetic depletion, import assays, Co-IP, and HPD-motif mutagenesis in yeast

   PMID:14517234

   Open questions at the time

   • Did not address regulation of J-domain activity by partner subunits
   • Human ortholog not directly characterized
2. 2004 High

   Identified the regulatory partner Pam16 and showed it antagonizes Pam18-mediated mtHsp70 ATPase stimulation, revealing that cochaperone output is held in check by a J-like partner.

   Evidence In vitro ATPase assays, genetic complementation, and HPD-mutant inhibition assays in yeast

   PMID:15218029

   Open questions at the time

   • Structural basis of the Pam16 antagonism not resolved
   • Whether inhibition operates at the translocon in vivo not yet defined
3. 2005 Medium

   Connected the gene to human disease, localizing DNAJC19 to the cardiac inner mitochondrial membrane and identifying a splice-site mutation causing DCMA syndrome.

   Evidence Homozygosity mapping, mutation sequencing, RT-PCR, and bioinformatics

   PMID:16055927

   Open questions at the time

   • Mechanism inferred by homology to yeast Tim14 rather than direct human assays
   • Did not establish how import defect produces cardiomyopathy
4. 2005 High

   Showed the motor harbors a second J-protein, Mdj2, that can functionally substitute for Tim14, refining understanding of J-protein redundancy at the translocon.

   Evidence Yeast deletion strains, co-purification, ATPase assays, and overexpression complementation

   PMID:16027163

   Open questions at the time

   • Physiological role of two J-proteins not delineated
   • No mammalian counterpart of this redundancy described
5. 2006 High

   Provided the structural basis for heterodimer-regulated cochaperone activity by solving the Tim14-Tim16 complex, showing identical folds with divergent surfaces and lethal phenotypes upon complex disruption.

   Evidence X-ray crystallography with mutagenesis, ATPase assays, and yeast viability tests

   PMID:16977310

   Open questions at the time

   • Structure of the full translocon-bound module not resolved
   • Human complex structure not determined
6. 2007 High

   Defined how the heterodimer docks onto the translocon, mapping three interactions and assigning Tim16 the dominant tethering role via its hydrophobic N-terminus, and showed heterodimer formation thermally stabilizes both subunits.

   Evidence Co-purification, suppressor screens, domain mapping, import assays, CD spectroscopy and crosslinking in yeast

   PMID:17242434 PMID:17452317 PMID:18003975

   Open questions at the time

   • Dynamics of docking during active import not captured
   • Quantitative contribution of each contact to import flux unresolved
7. 2009 Medium

   Demonstrated cross-species conservation by showing human DNAJC19 and human Tim16 form heterodimers and engage mtHsp70 even when paired with yeast counterparts, extending the yeast model to the human proteins.

   Evidence Recombinant protein purification and in vitro cross-species heterodimer binding assays

   PMID:19564938

   Open questions at the time

   • No functional import assay in human mitochondria
   • Native human translocon context not tested
8. 2011 Medium

   Revised the regulatory model, showing the Pam18:Pam16 interaction primarily serves to physically tether Pam18 to the translocon rather than to inhibit its activity, and identified a Pam16 region required to form an active stimulatory complex.

   Evidence ATPase assays, genetic interaction analysis, and domain mapping in yeast

   PMID:22031295

   Open questions at the time

   • Reconciliation with the earlier antagonism model not fully settled
   • Region of Pam16 not structurally defined
9. 2014 High

   Uncovered a second, import-independent function by showing DNAJC19 partners with prohibitin domains to regulate tafazzin-mediated cardiolipin remodeling and cristae morphology, linking it directly to membrane lipid homeostasis.

   Evidence PHB2 interactome MS, reciprocal Co-IP, cardiolipin lipidomics, and knockout/knockdown phenotyping

   PMID:24856930

   Open questions at the time

   • Molecular mechanism by which DNAJC19 controls tafazzin not defined
   • Relationship between import role and cardiolipin role unresolved
10. 2022 High

    Revealed a moonlighting function in which heterodimer disruption redistributes Pam18 to respiratory chain supercomplexes as a homodimer, where it promotes mtHsp70-dependent complex assembly at the cost of import.

    Evidence Yeast genetics, Co-IP, import assays, and respiratory chain assembly assays

    PMID:35385740

    Open questions at the time

    • Whether human DNAJC19 shares this dual localization not tested
    • Trigger for physiological redistribution unknown
11. 2023 High

    Connected the disease truncation to cellular phenotype, showing loss of the DnaJ interaction domain drives mitochondrial fragmentation, cristae defects, metabolic reprogramming, ROS elevation and Ca2+ dysregulation in cardiomyocytes.

    Evidence Patient-derived and CRISPR-edited iPSC-cardiomyocytes with EM, Seahorse respirometry, tracer uptake, ROS and Ca2+ imaging

    PMID:38142971

    Open questions at the time

    • Whether phenotypes arise from import loss, cardiolipin loss, or both not separated
    • In vivo cardiac consequences not modeled
12. 2025 Medium

    Identified a quality-control axis showing the Lon/Pim1 matrix protease degrades Pam18 and regulates its proteostasis, adding a layer of post-translational control over motor J-protein levels.

    Evidence In vitro degradation with purified Lon/Pim1 and in vivo Δpim1 yeast genetics with overexpression

    PMID:41099349

    Open questions at the time

    • Conservation of Lon-mediated turnover for human DNAJC19 not shown
    • Physiological signals triggering degradation undefined

• How DNAJC19's matrix import function and its prohibitin/cardiolipin remodeling function are mechanistically integrated, and which loss best explains DCMA pathology, remains unresolved.
• No structure or biochemical reconstitution of the DNAJC19-prohibitin-tafazzin module
• Causal hierarchy among import defect, cardiolipin defect, and cardiomyopathy not established
• Human-specific functional import assays largely absent